Overview
Nuclear Medicine Journal focuses on tracer development theranostics and quantitative PET SPECT methods; it highlights translational studies and clinical trials; articles emphasize dosimetry standardization and multicenter harmonization.
Tracer Development
Papers describe novel radiotracers for oncology neurology and cardiology; radiochemistry methods and production logistics are detailed; clinical translation challenges and regulatory pathways are discussed.
Quantification and Standards
Studies address SUV harmonization kinetic modeling and cross center calibration; guidelines for quantitative PET SPECT are proposed and validated; reproducible methods and phantom based QA are emphasized.
Theranostics and Therapy
Research on targeted radiopharmaceutical therapy and imaging biomarkers is featured; clinical outcomes safety and patient selection criteria are reported; multidisciplinary collaboration with oncology is highlighted.